Trial Profile
The influence of saxagliptin as add-on therapy to premixed insulin on the glucolipid metabolism in elderly, insulin-requiring patients with type 2 diabetes mellitus.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jan 2017
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Jan 2017 New trial record